Register entry
LABORATOIRE HRA PHARMA
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 8
- Countries
- 0
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9844510 | ELLAulipristal acetate | product | Dec 2028 |
| 8735380 | ELLAulipristal acetate | product | Feb 2029 |
| 10159681 | ELLAulipristal acetate | use | Apr 2030 |
| 10772897 | ELLAulipristal acetate | use | Apr 2030 |
| 9283233 | ELLAulipristal acetate | use | Apr 2030 |
| 8512745 | ELLAulipristal acetate | product | Jun 2030 |
| 8426392 | ELLAulipristal acetate | use | Jun 2030 |
| 8962603 | ELLAulipristal acetate | use | Jun 2030 |
Enquiry
Common questions
- Is LABORATOIRE HRA PHARMA FDA approved?
- LABORATOIRE HRA PHARMA holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.